EPMA Journal is a journal of predictive, preventive and personalized medicine (PPPM). The journal provides expert viewpoints and research on medical innovations and advanced healthcare using predictive diagnostics, targeted preventive measures and personalized patient treatments. The journal is indexed by PubMed, Embase and Scopus.
- The only journal in the field of predictive, preventive and personalized medicine (PPPM)
- High visibility for your research
- Official journal of the European Association for Predictive, Preventive & Personalised Medicine
- Olga Golubnitschaja
- Publishing model
- Hybrid. Open Access options available
- 4.901 (2019)
- Impact factor
- 21 days
- Submission to first decision
- 89 days
- Submission to acceptance
- 124,537 (2019)
Differences in cohort study data affect external validation of artificial intelligence models for predictive diagnostics of dementia - lessons for translation into clinical practice
Authors (first, second and last of 9)
A risk model of prenatal screening markers in first trimester for predicting hypertensive disorders of pregnancy
Authors (first, second and last of 8)
Comparative cerebrospinal fluid metabolites profiling in glioma patients to predict malignant transformation and leptomeningeal metastasis with a potential for preventive personalized medicine
Authors (first, second and last of 12)
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Cannabis-inspired medical products are garnering increasing attention from the scientific community, general public, and health policy makers. A plethora of scientific literature demonstrates intricate engagement of the endocannabinoid system with human immunology, psychology, developmental processes, neuronal plasticity, signal transduction, and metabolic regulation. Despite the therapeutic potential, the adverse psychoactive effects and historical stigma, cannabinoids have limited widespread clinical application.
In this review, Reddy et al outline of the endocannabinoid system and provide an in-depth discussion of the therapeutic interventions by endocannabinoids in various neurological disorders.
View the latest Editor-in-Chief highlights from EPMA Journal.
Dr. Golubnitschaja is the head of the world's first Predictive, Preventive and Personalised (3P) Medicine unit at the Department of Radiation Oncology, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany.
Societies, partners and affiliations
About this journal
- Electronic ISSN
- Print ISSN
- Abstracted and indexed in
- CAB Abstracts
- EBSCO Discovery Service
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- OCLC WorldCat Discovery Service
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Science Citation Index Expanded (SciSearch)
- UGC-CARE List (India)